0001209191-23-024915.txt : 20230419
0001209191-23-024915.hdr.sgml : 20230419
20230419190653
ACCESSION NUMBER: 0001209191-23-024915
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230417
FILED AS OF DATE: 20230419
DATE AS OF CHANGE: 20230419
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farrell Robert E Jr
CENTRAL INDEX KEY: 0001592280
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38940
FILM NUMBER: 23831060
MAIL ADDRESS:
STREET 1: CAMBRIDGE DISCOVERY PARK
STREET 2: 100 ACORN PARK DRIVE, 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Morphic Holding, Inc.
CENTRAL INDEX KEY: 0001679363
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473878772
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE A2
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 9787296480
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE A2
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Morphic Holding, LLC
DATE OF NAME CHANGE: 20160712
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-17
0
0001679363
Morphic Holding, Inc.
MORF
0001592280
Farrell Robert E Jr
C/O MORPHIC HOLDING, INC.
35 GATEHOUSE DRIVE, A2
WALTHAM
MA
02451
0
1
0
0
SVP Finance and CAO
1
Common Stock
2023-04-17
4
S
0
10000
40.00
D
12222
D
Common Stock
2023-04-17
4
S
0
10000
42.5001
D
2222
D
Common Stock
2023-04-19
4
M
0
10000
4.32
A
12222
D
Stock Option (right to buy Common Stock)
4.32
2023-04-19
4
M
0
10000
0.00
D
2028-12-14
Common Stock
10000
50270
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.50 to $42.51 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option is fully vested.
/s/ Robert Farrell, Jr.
2023-04-19